Find en forsker – Københavns Universitet

Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: A placebo-controlled, randomized study

Research output: Contribution to journalJournal articleResearchpeer-review

Morten Dalsgaard, Kasper Iversen, Jesper Kjaergaard, Peer Grande, Jens Peter Goetze, Peter Clemmensen, Christian Hassager

BACKGROUND: In patients with severe aortic stenosis (AS), treatment with angiotensin-converting enzyme inhibitors has previously been considered contraindicated. However, there is a lack of clinical evidence to confirm these potential hemodynamic risks and benefits.

METHODS: Forty-four patients with severe AS (aortic valve area <1 cm(2)) were randomized to treatment with trandolapril 22 mg daily/placebo (1:1). Right heart catheterization and echocardiography were performed at rest and during exercise at baseline and on day 3. Follow-up was performed before valve replacement or after a maximum of 8 weeks, when exercise echocardiography was repeated.

RESULTS: Compared with placebo, systolic blood pressure and systemic arterial compliance significantly changed at day 3 (-14 ± 11 vs -5 ± 13 mm Hg, P = .02, and 0.08 ± 0.16 vs -0.05 ± 0.86 mL/m(2) per mm Hg, P = .03, respectively). Changes in left ventricular end systolic volume (LVESV) was nonsignificant (-8 ± 9 vs -3 ± 11 mL, P = .17). At a median of 49 days of follow-up, changes in LVESV and N-terminal pro-brain natriuretic peptide were even lower revealing significant differences between the groups (-7.8 ± 2.6 vs -0.5 ± 2.5 mL, P = .04, and -19 ± 7 vs 0.8 ± 6 pmol/L, P = .04, respectively). No episodes of symptomatic hypotension were noted, and other hemodynamic parameters remained unchanged.

CONCLUSION: Angiotensin-converting enzyme inhibition in severe AS caused a decrease in LVESV and N-terminal pro-brain natriuretic peptide with other hemodynamic parameters preserved both at rest and during exercise implying hemodynamic improvement with left ventricular unloading.

Original languageEnglish
JournalAmerican Heart Journal
Volume167
Issue number2
Pages (from-to)226-234
Number of pages9
ISSN0002-8703
DOIs
StatePublished - Feb 2014

    Research areas

  • Aged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors, Aortic Valve Stenosis, Dose-Response Relationship, Drug, Double-Blind Method, Echocardiography, Exercise Test, Female, Follow-Up Studies, Hemodynamics, Humans, Indoles, Male, Middle Aged, Prospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome

ID: 138173469